Nu-Med Plus (NUMD) Other financing activities (2018 - 2021)

Nu-Med Plus (NUMD) posted Other financing activities of $30000.0 for Q1 2021, up 6.16% sequentially from $28260.0 in Q4 2020.

Nu-Med Plus (NUMD) Other financing activities (2018 - 2021) Analysis & Trends

Nu-Med Plus has reported Other financing activities for 4 years, with the latest figure at $30000.0 in Q1 2021.

Quarterly Other financing activities changed N/A year-over-year to $30000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was $416842.0 (up 857.89% YoY) and the FY2020 annual result came in at $386842.0, up 673.68% from the prior year.
Other financing activities grew to $30000.0 in Q1 2021 per NUMD's latest filing, from $28260.0 in the prior quarter.
Over five years, Other financing activities peaked at $232170.0 in Q2 2020 and troughed at -$225016.0 in Q4 2019.
A 4-year average of $55153.5 and a median of $85008.0 in 2019 frame the typical range for Other financing activities.
The widest YoY moves for Other financing activities: up 1177.37% in 2019, down 248.11% in 2019.
Over 4 years, Other financing activities stood at $151930.0 in 2018, then plunged by 248.11% to -$225016.0 in 2019, then surged by 112.56% to $28260.0 in 2020, then climbed by 6.16% to $30000.0 in 2021.
According to Business Quant data, Other financing activities over the past three periods registered $30000.0, $28260.0, and $126412.0 for Q1 2021, Q4 2020, and Q3 2020 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.52 Bn	193.92 Bn	7.27 Bn
2	Stryker	127.77 Bn	124.29 Bn	4.50 Bn
3	Medtronic	119.02 Bn	109.80 Bn	6.41 Bn
4	Boston Scientific	73.50 Bn	72.96 Bn	3.85 Bn
5	Edwards Lifesciences	51.91 Bn	47.66 Bn	1.35 Bn
6	Dexcom	34.36 Bn	32.41 Bn	830.00 Mn
7	GE HealthCare Technologies	33.87 Bn	31.76 Bn	2.18 Bn
8	Koninklijke Philips	26.39 Bn	23.07 Bn	4.55 Bn
9	Steris	23.07 Bn	22.58 Bn	684.20 Mn
10	Nu-Med Plus	2.03 Mn	2.02 Mn	-

Download Data